NDC 65862-739 – Amlodipine and valsartan
Amlodipine Besylate 10 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Oral
Product NDC65862-739
Product details
- Brand name
- Amlodipine and valsartan
- Generic name
- Amlodipine and valsartan
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA206512
- Marketed since
- April 22, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
Active ingredients
- Amlodipine Besylate 10 mg/1
- Valsartan 160 mg/1
Uses, dosage, side effects and warnings for Amlodipine And Valsartan →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 65862-739-03 | 3 BLISTER PACK in 1 CARTON (65862-739-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-739-10) | Apr 22, 2016 |
| 65862-739-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-739-30) | Apr 22, 2016 |
| 65862-739-90 | 90 TABLET, FILM COATED in 1 BOTTLE (65862-739-90) | Apr 22, 2016 |
Recalls mentioning this NDC
- D-1036-2019 Mar 27, 2019 · Class II
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product. - D-0364-2019 Jan 23, 2019 · Class II
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083… - D-0362-2019 Jan 23, 2019 · Class II
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083… - D-0361-2019 Jan 23, 2019 · Class II
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083… - D-0363-2019 Jan 23, 2019 · Class II
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083…
Other Amlodipine And Valsartan products
- 62332-205 Amlodipine Besylate 5 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-208 Amlodipine Besylate 10 mg/1; Valsartan 320 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-206 Amlodipine Besylate 10 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 62332-207 Amlodipine Besylate 5 mg/1; Valsartan 320 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.
- 46708-461 Amlodipine Besylate 10 mg/1; Valsartan 320 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-459 Amlodipine Besylate 10 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-458 Amlodipine Besylate 5 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 46708-460 Amlodipine Besylate 5 mg/1; Valsartan 320 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Limited
- 65862-738 Amlodipine Besylate 5 mg/1; Valsartan 320 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 65862-740 Amlodipine Besylate 10 mg/1; Valsartan 320 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 65862-737 Amlodipine Besylate 5 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 0378-1722 Amlodipine Besylate 10 mg/1; Valsartan 160 mg/1 · Tablet, Film Coated · Mylan Pharmaceuticals Inc.